Cargando…
Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19
Autores principales: | Ji, Dong, Zhang, Mingjie, Qin, Enqiang, Zhang, Lunqing, Xu, Jing, Wang, Yudong, Cheng, Gregory, Wang, Feng, Lau, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674072/ https://www.ncbi.nlm.nih.gov/pubmed/33220249 http://dx.doi.org/10.1016/j.metabol.2020.154437 |
Ejemplares similares
-
Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020) -
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
por: Ji, Dong, et al.
Publicado: (2020) -
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
por: Tripodi, Armando, et al.
Publicado: (2022) -
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020) -
Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)